Deliberations are complete and final votes cast for the winners of the 2015 Giants of Cancer Care™ Award recognizing individuals who have achieved landmark success in the field of oncology. Twelve honorees have been chosen from a pool of elite national and international physicians who have made outstanding contributions to tumor-specific specialties, scientific advances, community outreach, immuno-oncology, or supportive/palliative care. The winners will be announced on Friday, May 29, during the 3rd Annual Giants of Cancer Care Awards reception in Chicago from 8:30 to 11 p.m. CDT at the Chicago Illuminating Company, at 2110 S. Wabash Avenue. Please check back on http://giants.onclive.com/ after the ceremony for the results.
An outstanding group of experts will guide discussions among a cross section of health plan leaders, providers, hospital officials, pharmaceutical representatives, and others who are working to bring new payment models to life, as the ACO and Emerging Healthcare Delivery Coalition is set to meet April 30-May 1, 2015 in San Diego, California
“Kind,” “selfless,” “the voice of reason” and “truly an extraordinary healer” were among the ways Denise Weiner described pediatric oncology nurse Laura Vasquez of Children’s Hospital Los Angeles, who cared for her daughter, Alexa, during her five-year battle with a malignant brain tumor. Through chemotherapy, radiation, brain resections, a bone marrow transplant and numerous experimental treatments, Vasquez continued caring for Alexa, stopping by the house to visit Alexa when she was not in the hospital and even sitting vigil during the young girl’s last hours.
The president of Medicine & Science at Cancer Treatment Centers of America and editor-in-chief of OncologyLive magazine argues the FDA’s recent approval of olaparib (Lynparza) for women with BRCA-mutated advanced ovarian cancer is too restrictive and should be offered to many more patients.